SAN FRANCISCO, CA—Researchers at the Gladstone Institutes and UC San Francisco (UCSF) have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.
Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.
Julie Langelier, Science Writer and Public Relations Specialist
Direct line: 415.734.5000
Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
SAN FRANCISCO, CA—How do you improve a Nobel Prize-winning discovery? Add a debilitating disease-causing gene mutation.
SAN FRANCISCO, CA—Direct microbial sequencing of environmental samples, such as from ocean water, hospital surfaces, and the human gut, have illuminated the vast number of microbes present in our world.
SAN FRANCISCO, CA—The Gladstone Institutes is pleased to present the second annual Ogawa-Yamanaka Stem Cell Prize to Douglas Melton, PhD.
SAN FRANCISCO, CA—Stem cell experts will discuss the future of cellular reprogramming and its therapeutic potential at the Cell Symposium “10 Years of iPSCs,” September 25–27, 2016 at the Claremont Hotel and Spa in Berkeley, Califo
SAN FRANCISCO, CA—Gladstone Senior Investigator Katerina Akassoglou, PhD, was awarded a prestigious multi-year, multi-million dollar grant from the National Institute of Neurological Disorders and Stroke (NINDS).
SAN FRANCISCO, CA—It is a historic time at the Gladstone Institutes; William S. “Bill” Price, III, has joined the Gladstone Trustees. Price replaces Albert A. Dorman, who served Gladstone for almost 30 years.
SAN FRANCISCO, CA—There is new hope in the fight against Huntington’s disease. Scientists at the Gladstone Institutes discovered that changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral symptoms in a mouse model of the disease.
SAN FRANCISCO, CA—With a trick of engineering, scientists at the Gladstone Institutes improved a potential weapon against inflammation and autoimmune disorders. Their work could one day benefit patients who suffer from inflammatory bowel disease or organ transplant rejection.
MAASTRICHT, THE NETHERLANDS and SAN FRANCISCO, CA, USA—Researchers at Maastricht University and the Gladstone Institutes tackled the challenge of improving the integration of disparate sources and types of data and advance scientists’ understanding of disease.